Literature DB >> 10735348

Appropriate use of psychotropic drugs in nursing homes.

T Gurvich1, J A Cunningham.   

Abstract

The Omnibus Budget Reconciliation Act (OBRA) of 1987 limited the use of psychotropic medications in residents of long-term care facilities. Updates of OBRA guidelines have liberalized some dosing restrictions, but documentation of necessity and periodic trials of medication withdrawal are still emphasized. Antidepressant drugs are typically underutilized in nursing homes. Tricyclic antidepressants have many side effects and thus are not preferred medications in elderly patients. Anxiety and insomnia are common problems in the institutionalized elderly. If behavioral measures are not successful, antidepressant medications with shorter half-lives may avoid drug accumulation, which can lead to excessive sedation, cognitive impairment and an increased risk for falls. In the elderly, antipsychotic medications can cause serious side effects, such as extrapyramidal symptoms and tardive dyskinesia. Newer antipsychotic drugs are less often associated with these side effects, but they should be used only for specific diagnoses and when behavioral and environmental measures are unsuccessful.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10735348

Source DB:  PubMed          Journal:  Am Fam Physician        ISSN: 0002-838X            Impact factor:   3.292


  10 in total

1.  [Chemical restraints in nursing homes in the federal state Vorarlberg, Austria--an analysis of nursing home documentation according to legal obligation and suggestions for future improvement].

Authors:  Eva Mann; Gabriele Meyer
Journal:  Wien Med Wochenschr       Date:  2008

Review 2.  Prescribing of psychotropics in the elderly: why is it so often inappropriate?

Authors:  Jane R Mort; Rajender R Aparasu
Journal:  CNS Drugs       Date:  2002       Impact factor: 5.749

3.  Use of neuroleptics: study of institutionalized elderly people in Montreal, Que.

Authors:  Nathalie Champoux; Johanne Monette; Michèle Monette; Guillaume Galbaud du Fort; Christina Wolfson; Jean-Pierre Le Cruguel
Journal:  Can Fam Physician       Date:  2005-05       Impact factor: 3.275

4.  Antipsychotic and benzodiazepine use among nursing home residents: findings from the 2004 National Nursing Home Survey.

Authors:  David G Stevenson; Sandra L Decker; Lisa L Dwyer; Haiden A Huskamp; David C Grabowski; Eran D Metzger; Susan L Mitchell
Journal:  Am J Geriatr Psychiatry       Date:  2010-12       Impact factor: 4.105

5.  Long-term effects of rivastigmine treatment on the need for psychotropic medications in nursing home patients with Alzheimer's disease : results of a 52-week open-label study.

Authors:  Keith Edwards; Barbara Koumaras; Michael Chen; Ibrahim Gunay; Dario Mirski
Journal:  Clin Drug Investig       Date:  2005       Impact factor: 2.859

6.  Quality of care for elderly residents in nursing homes and elderly people living at home: controlled observational study.

Authors:  Tom Fahey; Alan A Montgomery; James Barnes; Jo Protheroe
Journal:  BMJ       Date:  2003-03-15

7.  Measuring severe adverse events and medication selection using a "PEER Report" for nonpsychotic patients: a retrospective chart review.

Authors:  Daniel A Hoffman; Charles Debattista; Robert J Valuck; Dan V Iosifescu
Journal:  Neuropsychiatr Dis Treat       Date:  2012-06-21       Impact factor: 2.570

8.  Polypharmacy or medication washout: an old tool revisited.

Authors:  Daniel A Hoffman; Mark Schiller; James M Greenblatt; Dan V Iosifescu
Journal:  Neuropsychiatr Dis Treat       Date:  2011-10-20       Impact factor: 2.570

9.  Sleep medication use and incident dementia in a nationally representative sample of older adults in the US.

Authors:  Rebecca Robbins; Ralph J DiClemente; Andrea B Troxel; Girardin Jean-Louis; Mark Butler; David M Rapoport; Charles A Czeisler
Journal:  Sleep Med       Date:  2020-11-11       Impact factor: 3.492

10.  Prescription drug use and expenditures among dually eligible beneficiaries.

Authors:  Ann D Bagchi; Dominick Esposito; James M Verdier
Journal:  Health Care Financ Rev       Date:  2007
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.